Bevacizumab ELISA (mAb-based)
Enzyme immunoassay for the specific and quantitative determination of free Bevacizumab (Avastin) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Bevacizumab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies, even with its 5 pointmutation Fab counterpart (Ranibizumab) is excluded.
Reference: IG-AB104
Barcode: 8682754930134
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-AB104 789.68 KB
Material Safety Data Sheet (MSDS) IG-AB104 264.47 KB
Avastin® is a trademark of Genentech Inc./Roche.
The Kit at a glance:
| Required Volume (µL) | 10 |
| Incubation Time (min) | 100 |
| Sample | Serum or Plasma |
| Package Size | 96 Tests |
| Standard Range (µg/mL, 1000x) | 0-200 |
| Detection Limit (ng/mL) | 5 |
| Spike Recovery (%) | >95% |
| Shelf Life (years) | 2 |
Standard Curve:
